BRPI0918288A2 - derivados de pirrolidino- ciclopropano fundidos como inibidores seletivos de 11-beta-hidroxiesteroide disidrogenase do tipo 1 - Google Patents
derivados de pirrolidino- ciclopropano fundidos como inibidores seletivos de 11-beta-hidroxiesteroide disidrogenase do tipo 1Info
- Publication number
- BRPI0918288A2 BRPI0918288A2 BRPI0918288A BRPI0918288A BRPI0918288A2 BR PI0918288 A2 BRPI0918288 A2 BR PI0918288A2 BR PI0918288 A BRPI0918288 A BR PI0918288A BR PI0918288 A BRPI0918288 A BR PI0918288A BR PI0918288 A2 BRPI0918288 A2 BR PI0918288A2
- Authority
- BR
- Brazil
- Prior art keywords
- dehydrogenase
- beta
- selective inhibitors
- cyclopropane derivatives
- fused pyrrolidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08290822 | 2008-09-01 | ||
PCT/EP2009/005654 WO2010022850A1 (en) | 2008-09-01 | 2009-08-05 | Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0918288A2 true BRPI0918288A2 (pt) | 2015-12-22 |
BRPI0918288B1 BRPI0918288B1 (pt) | 2018-11-06 |
Family
ID=41095854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0918288A BRPI0918288B1 (pt) | 2008-09-01 | 2009-08-05 | derivados de pirrolidino-ciclopropano fundidos, medicamento, composição farmacêutica, e kit |
Country Status (15)
Country | Link |
---|---|
US (1) | US8486964B2 (pt) |
EP (1) | EP2321317B1 (pt) |
JP (1) | JP5579717B2 (pt) |
KR (1) | KR101707580B1 (pt) |
CN (1) | CN102137864B (pt) |
AR (1) | AR073224A1 (pt) |
AU (1) | AU2009287118B9 (pt) |
BR (1) | BRPI0918288B1 (pt) |
CA (1) | CA2735286C (pt) |
EA (1) | EA020238B1 (pt) |
ES (1) | ES2531633T3 (pt) |
IL (1) | IL211447A (pt) |
MX (1) | MX2011002181A (pt) |
WO (1) | WO2010022850A1 (pt) |
ZA (1) | ZA201102418B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9580422B2 (en) * | 2013-10-22 | 2017-02-28 | Bristol-Myers Squibb Company | Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
MA40759A (fr) | 2014-09-26 | 2017-08-01 | Pfizer | Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation |
EP3235813A1 (en) | 2016-04-19 | 2017-10-25 | Cidqo 2012, S.L. | Aza-tetra-cyclo derivatives |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4088652A (en) * | 1975-07-31 | 1978-05-09 | American Cyanamid Company | Acylazabicyclohexanes |
EP1585576A2 (en) * | 2003-01-08 | 2005-10-19 | MibiTech ApS | Electro-therapeutic device and method of electro-therapeutic treatment |
WO2004089896A1 (en) | 2003-04-11 | 2004-10-21 | Novo Nordisk A/S | 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS |
US7700583B2 (en) | 2003-04-11 | 2010-04-20 | High Point Pharmaceuticals, Llc | 11β-hydroxysteroid dehydrogenase type 1 active compounds |
WO2006106423A2 (en) * | 2005-04-07 | 2006-10-12 | Pfizer Inc. | Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
WO2007054577A1 (en) * | 2005-11-14 | 2007-05-18 | Probiodrug Ag | Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase iv inhibitors |
GB0625198D0 (en) * | 2006-12-18 | 2007-01-24 | Glaxo Group Ltd | Chemical compounds |
-
2009
- 2009-08-05 EA EA201100419A patent/EA020238B1/ru not_active IP Right Cessation
- 2009-08-05 JP JP2011524221A patent/JP5579717B2/ja active Active
- 2009-08-05 BR BRPI0918288A patent/BRPI0918288B1/pt active IP Right Grant
- 2009-08-05 CA CA2735286A patent/CA2735286C/en active Active
- 2009-08-05 US US13/061,238 patent/US8486964B2/en active Active
- 2009-08-05 KR KR1020117007670A patent/KR101707580B1/ko active IP Right Grant
- 2009-08-05 MX MX2011002181A patent/MX2011002181A/es active IP Right Grant
- 2009-08-05 AU AU2009287118A patent/AU2009287118B9/en active Active
- 2009-08-05 CN CN200980134854.6A patent/CN102137864B/zh active Active
- 2009-08-05 EP EP09777657.9A patent/EP2321317B1/en active Active
- 2009-08-05 ES ES09777657.9T patent/ES2531633T3/es active Active
- 2009-08-05 WO PCT/EP2009/005654 patent/WO2010022850A1/en active Application Filing
- 2009-08-28 AR ARP090103315A patent/AR073224A1/es unknown
-
2011
- 2011-02-27 IL IL211447A patent/IL211447A/en active IP Right Grant
- 2011-03-31 ZA ZA2011/02418A patent/ZA201102418B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN102137864A (zh) | 2011-07-27 |
IL211447A0 (en) | 2011-05-31 |
AU2009287118B2 (en) | 2014-02-27 |
MX2011002181A (es) | 2011-03-30 |
ES2531633T3 (es) | 2015-03-18 |
JP2012501302A (ja) | 2012-01-19 |
CN102137864B (zh) | 2014-12-31 |
KR20110059749A (ko) | 2011-06-03 |
BRPI0918288B1 (pt) | 2018-11-06 |
CA2735286A1 (en) | 2010-03-04 |
WO2010022850A1 (en) | 2010-03-04 |
AU2009287118B9 (en) | 2014-08-07 |
IL211447A (en) | 2014-07-31 |
AR073224A1 (es) | 2010-10-20 |
EP2321317A1 (en) | 2011-05-18 |
US8486964B2 (en) | 2013-07-16 |
JP5579717B2 (ja) | 2014-08-27 |
US20110172265A1 (en) | 2011-07-14 |
EA020238B1 (ru) | 2014-09-30 |
EA201100419A1 (ru) | 2011-10-31 |
AU2009287118A1 (en) | 2010-03-04 |
ZA201102418B (en) | 2011-12-28 |
KR101707580B1 (ko) | 2017-02-16 |
CA2735286C (en) | 2017-12-05 |
EP2321317B1 (en) | 2014-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0820236A2 (pt) | Derivados de piridazinona como inibidores parp | |
BRPI0812825A2 (pt) | Derivados ftalazinona como inibidores de parp-1 | |
DK2344682T3 (da) | Elektrode for elektrolysecelle | |
BRPI0913879A2 (pt) | fenilpirazinonas como inibidores de quinase | |
BRPI0920135A2 (pt) | imidazopiridazinacarbonitrilos úteis como inibidores de quinase | |
BRPI0911444A2 (pt) | benzoimidazóis como inibidores de prolil hidroxilase | |
BRPI0913931A2 (pt) | poliolefinas modificadas | |
BRPI0814441A2 (pt) | Compostos de amida heterocíclica como inibidores de proteína cinase | |
BR112012000792A2 (pt) | compostos heterocíclicos como inibidores de autotaxina | |
BRPI1009800A2 (pt) | compostos heterocíclicos como inibidores de autotaxina | |
BRPI0811065A2 (pt) | Indazóis 5-heteroaril substituídos como inibidores de quinase | |
BRPI0911347A2 (pt) | gama lactamas substituídas como agentes terapêuticos | |
BRPI0907641A2 (pt) | Piridinas fundidas ativas como inibidores de c-met | |
BRPI0818348A2 (pt) | Derivados de n-(pirazol-3-il)-benzamida como ativadores de glicocinase | |
BRPI0914724A2 (pt) | eletrodo para solda | |
BRPI0920239A2 (pt) | compostos heterocíclicos como inibidores de proteínas quinases | |
BRPI0912475A2 (pt) | compostos como inibidores de quinase | |
BRPI0910679A2 (pt) | 5-metil-1-(naftaleno-2-il)-1h-pirazóis úteis como inibidores de receptor sigma | |
IT1391986B1 (it) | Ciabatta di tipo perfezionato | |
BRPI0816161A2 (pt) | Transformante capaz de produzir isopropanol | |
BRPI0914268A2 (pt) | novo nrf2 oncogênico | |
BRPI0925050A2 (pt) | Compostos heterocíclicos como inibidores de mek | |
BRPI0817061A2 (pt) | Derivados de pirrolidinilalquilisoquinolinona e -isoindolinona como antagonistas de histamina-3 | |
BRPI0914305A2 (pt) | Compostos de piridazina carboxamida substituída como compostos inibidores da quinase | |
BRPI0914936A2 (pt) | naftiridininonas como inibidores de aurora quinase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/08/2009, OBSERVADAS AS CONDICOES LEGAIS. |